Sha Wu

1.5k total citations
30 papers, 924 citations indexed

About

Sha Wu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sha Wu has authored 30 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 16 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Sha Wu's work include CAR-T cell therapy research (8 papers), Extracellular vesicles in disease (6 papers) and Immune Cell Function and Interaction (5 papers). Sha Wu is often cited by papers focused on CAR-T cell therapy research (8 papers), Extracellular vesicles in disease (6 papers) and Immune Cell Function and Interaction (5 papers). Sha Wu collaborates with scholars based in China, United Kingdom and United States. Sha Wu's co-authors include Chenfei Zhou, Wei Wang, Lei Huang, Rui-Ming Yan, Luo-Jiao Liang, Wen-Fei Wei, Xiang‐Guang Wu, Xiaojing Chen, Yanmei Zhang and Mei Zhong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Sha Wu

29 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sha Wu China 15 497 373 353 305 78 30 924
Xiaojing Chen China 15 380 0.8× 445 1.2× 176 0.5× 351 1.2× 86 1.1× 34 856
Liangsheng Fan China 17 325 0.7× 133 0.4× 163 0.5× 232 0.8× 55 0.7× 29 591
Ava J. Boutilier United States 3 482 1.0× 605 1.6× 213 0.6× 348 1.1× 59 0.8× 5 1.1k
Xiaocheng Zhou China 16 623 1.3× 133 0.4× 488 1.4× 197 0.6× 55 0.7× 29 927
Yuzhen Feng China 14 462 0.9× 100 0.3× 145 0.4× 230 0.8× 60 0.8× 30 827
Xuhao Ni China 12 391 0.8× 411 1.1× 251 0.7× 273 0.9× 79 1.0× 16 967
Jiri Keirsse Belgium 12 412 0.8× 990 2.7× 187 0.5× 525 1.7× 79 1.0× 19 1.3k
Elio Schouppe Belgium 10 274 0.6× 764 2.0× 141 0.4× 413 1.4× 50 0.6× 12 1.0k
Camille L. Duran United States 12 347 0.7× 133 0.4× 167 0.5× 169 0.6× 19 0.2× 23 646
Yayi Hou China 12 1.3k 2.5× 226 0.6× 1.3k 3.6× 227 0.7× 95 1.2× 14 1.7k

Countries citing papers authored by Sha Wu

Since Specialization
Citations

This map shows the geographic impact of Sha Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sha Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sha Wu more than expected).

Fields of papers citing papers by Sha Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sha Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sha Wu. The network helps show where Sha Wu may publish in the future.

Co-authorship network of co-authors of Sha Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Sha Wu. A scholar is included among the top collaborators of Sha Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sha Wu. Sha Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Keke, Liang Tang, Xin Zhang, et al.. (2025). Lithium carbonate induces myofibroblast necroptosis to reverse pulmonary fibrosis. 1(1).
2.
Wang, Yuhan, et al.. (2024). Unveiling the pathological functions of SOCS in colorectal cancer: Current concepts and future perspectives. Pathology - Research and Practice. 262. 155564–155564. 1 indexed citations
3.
Chen, Jing, et al.. (2023). Oncogenic viral antigens for engineered T cell immunotherapy: Challenges and opportunities. SHILAP Revista de lepidopterología. 1(4). 306–317. 5 indexed citations
4.
Lu, Xinyu, et al.. (2023). Strategies and rules for tuning TCR-derived therapy. Expert Reviews in Molecular Medicine. 26. e4–e4. 1 indexed citations
5.
Li, Haokun, Manyi Wang, Edward Chu, et al.. (2022). mTOR participates in the formation, maintenance, and function of memory CD8+T cells regulated by glycometabolism. Biochemical Pharmacology. 204. 115197–115197. 9 indexed citations
6.
Zhou, Chenfei, Wen-Fei Wei, Jing Ma, et al.. (2021). Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels. Molecular Therapy. 29(4). 1512–1528. 102 indexed citations
7.
Zhou, Chenfei, Yanmei Zhang, Rui-Ming Yan, et al.. (2020). Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment. Cell Death and Differentiation. 28(2). 715–729. 77 indexed citations
8.
Zhang, Yanmei, Yang Yang, Zhimin Wang, et al.. (2020). CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8+ T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication. Frontiers in Immunology. 11. 1012–1012. 15 indexed citations
9.
Chen, Xiaojing, Zi‐Ci Wang, Wen-Fei Wei, et al.. (2019). Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment. Cell Death and Disease. 10(7). 508–508. 99 indexed citations
10.
Ma, Jing, Lan Yu, Fan Xu, et al.. (2019). Treatment and clinical outcomes of cervical cancer during pregnancy. Annals of Translational Medicine. 7(11). 241–241. 8 indexed citations
11.
Jiang, Xiaotao, Xu Jiang, Mingfeng Liu, et al.. (2019). Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities. Cancer Letters. 462. 23–32. 101 indexed citations
12.
Zhou, Chenfei, Wei Wang, Sha Wu, et al.. (2019). miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells. Stem Cell Research & Therapy. 10(1). 287–287. 37 indexed citations
13.
Zhou, Chenfei, Jing Ma, Lei Huang, et al.. (2018). Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1. Oncogene. 38(8). 1256–1268. 160 indexed citations
14.
Chen, Xiaojing, Sha Wu, Liangsheng Fan, et al.. (2018). The role of the hypoxia‐Nrp‐1 axis in the activation of M2‐like tumor‐associated macrophages in the tumor microenvironment of cervical cancer. Molecular Carcinogenesis. 58(3). 388–397. 79 indexed citations
15.
Wu, Sha, Wei Zhu, Yibing Peng, et al.. (2017). The Antitumor Effects of Vaccine-Activated CD8+ T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells. Cancer Immunology Research. 5(10). 908–919. 23 indexed citations
16.
Gong, Li, Yuanzhan Wang, Lili Zhou, et al.. (2014). Activation of Toll-like Receptor-7 Exacerbates Lupus Nephritis by Modulating Regulatory T Cells. American Journal of Nephrology. 40(4). 325–344. 16 indexed citations
17.
He, Yong, Xiaomei Yuan, Ping Lei, et al.. (2009). The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells. Acta Pharmacologica Sinica. 30(7). 1053–1059. 32 indexed citations
18.
Wang, Min, Ping Wang, Sha Wu, et al.. (2008). The altered expression of glucose-regulated proteins 78 in different phase of streptozotocin-affected pancreatic beta-cells. Cell Stress and Chaperones. 14(1). 43–48. 19 indexed citations
19.
Wei, Xing, Sha Wu, Xiaomei Yuan, et al.. (2008). The anti-tumor effect of human monocyte-derived dendritic cells loaded with HSV-TK/GCV induced dying cells. Cellular Immunology. 254(2). 135–141. 3 indexed citations
20.
Lei, Ping, Yong He, Wenfang Shi, et al.. (2007). Effect of Human WEE1 and Stem Cell Factor on Human CD34<sup>+</sup> Umbilical Cord Blood Cell Damage Induced by Chemotherapeutic Agents. Acta Biochimica et Biophysica Sinica. 39(8). 599–607. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026